Drug Development

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Articles

To achieve a more dynamic marketplace, FDA is issuingguidance documents and targeted advisories to support R&D on complex generics and combination products.

FDA Promotes Complex Generics and Combination Products

Amgen’s biosimilar to AbbVie’s Humira (adalimumab) is the first inflammation biosimilar from Amgen's portfolio to launch in Europe.

Amgen Launches Adalimumab Biosimilar in Europe

Cambrex will create a new center of excellence for API process development and clinical supply at its High Point, NC facility and expand its API manufacturing facility in Italy. 

Cambrex Development Center in North Carolina Focuses on Continuous Flow

The company’s planned investment in its alkoxylation facility in the United States Gulf Coast will also expand production capacity for its polyethylene glycols.

Dow Expands Capacity for Polyethlene Glycols

The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.

MilliporeSigma Offers Insect Platform for Viral Vaccines and Gene Therapy Development

Novartis’ Sandoz has reached a global patent resolution for Hyrimoz (adalimumab), its biosimilar to AbbVie’s Humira (adalimumab). 

Sandoz Humira Biosimilar Patent Dispute Resolved

A new investigational vaccine, LASSARAB, shows promise for use against Lassa fever and rabies.

Scientists Develop New Vaccine for Lassa Fever and Rabies

The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.

Almac Invests in Next-Generation Sequencing Capabilities

Advances in biologic drug development require increased methodological and technological innovation from the biopharma industry. Learn more at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.

Biologic Drugs Challenge the Biopharma Industry

Lonza’s Capsugel Colorista capsule R&D solution can cut overall development time and offers greater flexibility during technical color development.

Formulation and Drug Delivery